Company: BLNE
Filing Date: 2025-05-01
Form Type: 424B5
Source: 0001641172-25-008111
Chunk: 7

Company: Beeline Holdings, Inc.
Filing Date: 2025-05-01
Form: 424B5
Chunk 7
---
 adjusted) and 2,217,397 shares of common stock underlying warrants (as adjusted) each of which are presently subject to a 4.99% beneficial ownership limitation which as amended expires on June 25, 2025. See “Series G and Warrant Offering” below at page S-5.

Director and Officer Resignations and Appointments

On March 7, 2025, following the shareholder meeting described above, Geoffrey Gwin, Robert Grammen and Stephanie Kilkenny resigned as directors of the Company and Geoffrey Gwin resigned as Chief Executive Officer. Following such resignations, the Board of Directors (the “Board”) appointed Nicholas Liuzza, Jr. as Chief Executive Officer and a director and Stephen Romano as a director. The committees of the Board now consist of:

| S-4 |

Audit Committee

Eric Finnsson, Chairman

Joseph Freedman

Stephen Romano

Compensation Committee

Joseph Freedman, Chairman

Eric Finnsson

Stephen Romano

Corporate Governance and Nominating Committee

Joseph Caltabiano, Chairman

Joseph Freedman

Eric Finnsson

Series G and Warrant Offering

The Company commenced an offering of Series G shares and warrants on November 26, 2024. Since that date, the Company has sold to accredited investors a total of 12,274,023 shares of Series G and accompanying warrants to purchase 613,706 shares of common stock for total gross proceeds of $6,259,752. The Company also issued 1,088,721 shares of Series G in transactions outside of the offering. The Company used the net proceeds, after deducting offering expenses and related costs, for working capital and general corporate purposes and repayment of indebtedness.

On January 21, 2025, the Company amended its Articles of Incorporation to increase the number of authorized shares of the Company’s Series G to 11,000,000. On February 25, 2025, the Company further amended its Articles of Incorporation to increase the number of authorized shares of the Company’s Series G to 15,000,000.On February 27, 2025, the Company increased its offering of Series G and accompanying warrants to a total of up to 13,878,040 shares of Series G (originally convertible into 1,387,804 shares of common stock, subject to adjustment) and warrants to originally purchase up to 693,902 shares of common stock (representing 50% warrant coverage, subject to